Asset-light model, better prospects to help Dr Lal, Thyrocare outperform players like Apollo Hospitals
However, medium-term outlook remains strong; use stock correction as buying opportunity, say analysts
US sales continue to decline, pressuring profit and dampening the Street sentiment
Steady rental income offers support amid uncertainty and sluggish demand for residential space
Benefits will be visible a year from now
It'll reduce debt, boost muscle to take on Reliance Jio, bring down Airtel discount due to Infratel
But company hopeful of better performance in rest of financial year on agriculture exports
Analysts are positive on the stock, given new product launches and attractive valuations
Analysts are bullish on the product cycle of the passenger vehicles
Will create India's largest media entity; existing brands to continue; transaction expected to close in 2nd half of 2017
The company has hiked its guidance for tractor volume growth to 20% in the current financial year
Revenues grew 15.6% to Rs 10,172 crore due to price hikes taken across product range in June quarter
New order wins should help raise, diversify revenue base; rising profit to drive earnings, stock
Company maintains operating-profit margin forecast at 16-18 per cent for FY17
British drug maker GSK's global CEO Sir Andrew Witty will step down next March after eight years
A better performance in the second half of this financial year could have a positive impact on the stock
Results in line with estimates, but rise in lead prices and competition could weigh on profit
Settlement with Mylan and strong forecast for the second half of FY17 are positives
Higher raw material costs and pricing pressures might pose risks to margin improvement
Muted September quarter additions and Arpu pressures are an overhang